KR101086528B1 - New isoflavonoids of Cordyceps militaris grown in the germinated soybean - Google Patents

New isoflavonoids of Cordyceps militaris grown in the germinated soybean Download PDF

Info

Publication number
KR101086528B1
KR101086528B1 KR1020080102519A KR20080102519A KR101086528B1 KR 101086528 B1 KR101086528 B1 KR 101086528B1 KR 1020080102519 A KR1020080102519 A KR 1020080102519A KR 20080102519 A KR20080102519 A KR 20080102519A KR 101086528 B1 KR101086528 B1 KR 101086528B1
Authority
KR
South Korea
Prior art keywords
soybean
cordyceps
formula
germinated soybean
acid
Prior art date
Application number
KR1020080102519A
Other languages
Korean (ko)
Other versions
KR20100043471A (en
Inventor
이충환
박동기
최정남
김지영
이미연
임채성
Original Assignee
(주)세포활성연구소
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)세포활성연구소 filed Critical (주)세포활성연구소
Priority to KR1020080102519A priority Critical patent/KR101086528B1/en
Publication of KR20100043471A publication Critical patent/KR20100043471A/en
Application granted granted Critical
Publication of KR101086528B1 publication Critical patent/KR101086528B1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/06Benzopyran radicals
    • C07H17/065Benzo[b]pyrans
    • C07H17/07Benzo[b]pyran-4-ones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26Acyclic or carbocyclic radicals, substituted by hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

본 발명은 발아 대두 동충하초(Cordyceps militaris grown in the germinated soybean)로 부터 분리한 신규 천연물에 관한 것으로서, 더욱 상세하게는 동충하초(Cordyceps militaris)를 대두에 접종하여 발아시킨 것을 80% 메탄올로 추출한 추출액 중 에틸아세테이트 가용부를 분리하여 젤여과크로마토그래피하여 분리된 신규 이소플라본 계열 화합물 및 이를 분리하는 방법에 관한 것으로, 이와 같은 본 발명은 본 발명에 따른 발아대두 동충하초 추출물 및 화학식 1, 2, 3, 4로 표시되는 화합물은 현재까지 보고되지 않은 신규 이소플라본 계열의 화합물로써 신규 기능성 생리활성 물질을 이용한 약제 개발에 유용하다.The present invention germinated soybean cordyceps ( Coldyceps militaris grown in the germinated soybean) is a new natural product, and more specifically, Cordyceps militaris inoculated with soybean germination was isolated by gel filtration chromatography by separating the soluble part of ethyl acetate in 80% methanol extract The present invention relates to an isoflavone-based compound and a method for separating the same, and the present invention relates to the germinated soybean Cordyceps sinensis extract and the compound represented by the formulas (1), (2), (3) and (4) according to the present invention. It is useful for the development of a drug using a novel functional bioactive substance as a compound.

동충하초(Cordyceps militaris), 대두(soybean), 이소플라본(isoflavone) Cordyceps militaris, soybean, isoflavone

Description

발아 대두 동충하초로부터 분리된 신규 이소플라본 계열 화합물{New isoflavonoids of Cordyceps militaris grown in the germinated soybean}New isoflavonoids of Cordyceps militaris grown in the germinated soybean}

본 발명은 발아 대두 동충하초(Cordyceps militaris grown in the germinated soybean)로부터 분리된 신규 이소플라본 계열 화합물 및 그 분리 방법에 관한 것으로, 보다 상세하게는, 동충하초(Cordyceps militaris)를 대두에 접종하여 발아시킨 것을 80% 메탄올로 추출한 추출액 중 에틸아세테이트 가용부를 젤여과크로마토그래피하여 분리된 신규 이소플라본 계열 화합물 및 그 분리 방법에 관한 것이다.The present invention germinated soybean cordyceps ( Coldyceps militaris grown in the germinated soybean) and isoflavone-based compounds isolated from the soybean, and more particularly, gel filtration chromatography of the ethyl acetate soluble part of the extract extracted with 80% methanol from the inoculation of Cordyceps militaris in soybean germination The present invention relates to a novel isoflavone-based compound separated by grafting and a method for separating the same.

일반적으로, 대두에 많이 함유 되어 있는 이소플라본 계열 화합물은 체내 여성 호르몬인 에스트로겐과 유사한 작용을 하는 화합물로서 실제 체내에서 에스트로겐의 작용을 차단하는 효과를 나타내기도 하고, 에스트로겐이 부족한 상황에서는 이를 활성화시키는 기능도 할 수 있는 것으로 알려져 있다. 특히 대두에 존재하는 이소플라본계열 화합물, 그중에서도 대표적인 다이드제인(Daidzein)과 제니스테인(Genistein)은 유방암 발생의 위험을 현저히 낮추는 것으로 보고되어 있으며 전 립선암의 발생률 또한 저해하는 것으로 보고되어져 있다. 또한 대두의 아이소플라본계열 화합물은 항산화 효과와 핏속의 나쁜 콜레스테롤을 낮추는 작용이 있어 동맥경화와 심장병을 예방한다. In general, isoflavone-based compounds in soybeans are compounds that function similar to estrogen, a female hormone in the body, and have the effect of blocking the action of estrogen in the body, and activate it in a situation of lack of estrogen. It is known to be possible. In particular, isoflavone-based compounds present in soybeans, among which typical Dadezein and Genistein, have been reported to significantly reduce the risk of breast cancer, and have been reported to inhibit the incidence of prostate cancer. In addition, the isoflavone-based compound of soybean has an antioxidant effect and lowers bad cholesterol in the blood, thereby preventing atherosclerosis and heart disease.

동충하초는 중국, 일본 등지에서 일찍이 불로장생의 비약으로 알려져 있고, 이를 이용하여 아편 해독제, 병후 보양 및 강장제, 폐병 치료제, 면역증가제 등으로 가치를 인정받고 있다. 국외에서는 일찍부터 미래의 식량자원으로서 균류에 대한 관심이 집중되면서 특히 동충하초균과 같은 고등균류에 대한 연구는 기초적인 연구 뿐만 아니라 이를 이용하여 식품, 의약품 및 천연농약제제로서 상품화 연구가 진행 중에 있으며, 국내에서는 번데기 동충하초(Cordyceps militaris)와 눈꽃 동충하초(누에동충하초, Paecilomyces tenupis)를 번데기나 누에에서 인공배양에 성공하여 실용화되고 있으며, 최근 암, 뇌졸중, 심장병과 같은 성인병에 대한 예방 및 개선효과가 발견되어 무한한 잠재력을 가진 소재로 각광받고 있다. 동충하초에서 유래된 코디세핀(Cordycepin), 다당체 등의 각종 생리활성 성분이 항암효과를 나타냄이 보고된 바 있다. 이러한 대두와 동충하초(Cordyceps militaris)의 다양한 생리활성에 근간하여 발아대두에 동충하초 종균을 접종 배양하여 생산된 발아대두 동충하초(Cordyceps militaris grown in the germinated soybean)에서 개선된 생리활성 물질이 개발될 수 있음을 확신하며, 이를 위해 각종 유용물질을 분리 동정, 효능평가 및 검정이 필요하다.Cordyceps sinensis is known as a elixir of immortality in China, Japan, etc., and has been recognized for its value as an opioid antidote, post-care and tonic, pulmonary disease treatment, and immune booster. Overseas, as interest in fungi as a food source for the future has been concentrated, research on higher fungi, especially Cordyceps fungus, is being conducted not only as a basic research but also as a food, medicine, and natural pesticide product. In Korea, Cordyceps militaris and Snowflower Cordyceps ( Paecilomyces tenupis ) have been successfully used in pupae or silkworms and have been successfully applied. Recently, prevention and improvement of adult diseases such as cancer, stroke and heart disease have been found. It is spotlighted as a material with infinite potential. It has been reported that various bioactive components such as cordycepin and polysaccharide derived from Cordyceps sinensis have anti-cancer effects. These soybeans and various fungus and based on physiological activity produced by culturing the fungus inoculated seed germination in soybean Soybean Germination of Cordyceps (Cordyceps militaris) (Cordyceps militaris grown in the germinated It is convinced that improved bioactive substances can be developed in soybean), and it is necessary to identify, identify and evaluate various useful substances.

따라서, 상기한 바와 같은 문제점을 해결하기 위한 본 발명의 목적은 발아대두 동충하초(Cordyceps militaris grown in the germinated soybean)로부터 신규 고기능성 생리활성 물질을 분리하는 연구를 하였고, 그 결과 발아 대두 동충하초로부터 분리된 신규 이소플라본계열 화합물을 추출 정제하고 이들의 구조를 규명하도록 한 발아 대두 동충하초로부터 분리된 신규 이소플라본 계열 화합물을 제공하는데 있다.Accordingly, it is an object of to solve the problems as described above, the present invention is Cordyceps (Cordyceps militaris germinated soybeans grown in the germinated Soybean) was used to isolate novel high-functional physiologically active substances, and as a result, new isoflavones isolated from germinated soybean cordyceps were extracted and purified to identify their structure. To provide a compound.

또한, 본 발명의 또 다른 목적은 발아 대두 동충하초(Cordyceps militaris grown in the germinated soybean)를 80% 메탄올 추출 및 추출물의 에틸아세테이트 가용부를 젤여과크로마토그래피하여 신규 이소플라본계열 화합물을 분리하는 분리 방법을 제공하는 데 있다.In addition, another object of the present invention is germinated soybean Cordyceps militaris grown in the germinated soybean) and 80% methanol extraction and ethyl acetate soluble part of the extract to provide a separation method to separate the novel isoflavone-based compounds by gel filtration chromatography.

상기한 목적을 달성하기 위하여 본 발명에 의한 발아 대두 동충하초로부터 분리된 신규 이소플라본 계열 화합물은, 다음의 화학식 1, 2, 3, 4로 표시되는 이소플라본 계열 화합물인 것을 특징으로 한다.In order to achieve the above object, the novel isoflavone-based compound isolated from germinated soybean cordyceps according to the present invention is an isoflavone-based compound represented by the following formulas (1), (2), (3) and (4).

(화학식 1)(Formula 1)

Figure 112008072659540-pat00001
Figure 112008072659540-pat00001

(화학식 2)(Formula 2)

Figure 112008072659540-pat00002
Figure 112008072659540-pat00002

(화학식 3)(Formula 3)

Figure 112008072659540-pat00003
Figure 112008072659540-pat00003

(화학식 4)(Formula 4)

Figure 112008072659540-pat00004
Figure 112008072659540-pat00004

또한, 본 발명에 의한 발아 대두 동충하초로부터 분리된 신규 이소플라본 계열 화합물을 분리하는 방법은, 발아 대두 동충하초(Cordyceps militaris grown in the germinated soybean)를 80% 저급메탄올로 추출하는 제1 단계와, 상기 저급알콜 추출액을 에틸아세테이트로 진탕추출하여 에틸아세테이트 가용부를 회수하는 제2 단계와, 상기 에틸아세테이트 가용부를 젤여과크로마토그래피하여 활성분획을 얻는 제3 단계와, 상기 활성분획을 감압 농축하는 제4 단계, 및 감압 농축된 분말을 고성능 액체 크로마토그래피(High Perfomance Liquid Chromatography)를 이용하여 단일 순수 화합물로 얻는 제5 단계로 이루어진 것을 특징으로 한다. In addition, the method for isolating a novel isoflavone-based compound isolated from germinated soybean Cordyceps sinensis according to the present invention, Germinated soybean Cordyceps sinensis ( Cordyceps militaris grown in the germinated soybean) extracted with 80% lower methanol, the second step of extracting the lower alcohol extract with ethyl acetate to recover the ethyl acetate soluble part, and the ethyl acetate soluble part by gel filtration chromatography with active fractions A third step of obtaining, a fourth step of concentrating the active fraction under reduced pressure, and a fifth step of obtaining the concentrated powder under reduced pressure as a single pure compound using high performance liquid chromatography (High Perfomance Liquid Chromatography) .

본 발명에 따른 발아대두 동충하초 추출물 및 화학식 1, 2, 3, 4로 표시되는 화합물은 현재까지 보고되지 않은 신규 이소플라본 계열의 화합물로써 신규 기능성 생리활성 물질을 이용한 약제 개발에 유용하다.Germinated soybean Cordyceps sinensis extract and the compounds represented by the formulas (1), (2), (3) and (4) according to the present invention are novel isoflavone-based compounds that have not been reported to date, and are useful for the development of drugs using novel functional bioactive substances.

이하, 본 발명의 실시예를 첨부된 도면을 참조하여 상세히 설명한다. Hereinafter, embodiments of the present invention will be described in detail with reference to the accompanying drawings.

본 발명은 화학식 1, 2, 3, 4로 표시되는 신규 이소 플라본 계열 화합물과, 발아 대두 동충하초(Cordyceps militaris grown in the germinated soybean)로부터 이러한 신규 화합물을 추출 분리하는 방법에 관한 것이다. The present invention is a novel isoflavone-based compound represented by the formula (1), (2), (3), (4), and germinated soybean cordyceps ( Cordyceps militaris grown in the germinated) soybean) to extract and isolate such a novel compound.

상기한 바대로, 본 발명은 하기의 화학식 1, 2, 3, 4로 표시되는 화합물은 유기 합성방법으로 합성할 수 있고, 또는 본 발명의 방법에 따라 발아 대두 동충하초로 부터 추출 분리할 수도 있다.As described above, in the present invention, the compounds represented by the following Chemical Formulas 1, 2, 3, and 4 may be synthesized by an organic synthesis method, or may be extracted and separated from germinated soybean cordyceps according to the method of the present invention.

(화학식 1)(Formula 1)

Figure 112008072659540-pat00005
Figure 112008072659540-pat00005

(화학식 2)(Formula 2)

Figure 112008072659540-pat00006
Figure 112008072659540-pat00006

(화학식 3)(Formula 3)

Figure 112008072659540-pat00007
Figure 112008072659540-pat00007

(화학식 4)(Formula 4)

Figure 112008072659540-pat00008
Figure 112008072659540-pat00008

본 발명의 발아 대두 동충하초로부터 분리된 신규 이소플라본 계열 화합물을 추출 분리하는 방법은 다음 단계를 포함한다.The method for extracting and separating novel isoflavone family compounds isolated from germinated soybean cordyceps of the present invention includes the following steps.

발아 대두 동충하초(Cordyceps militaris grown in the germinated soybean)를 80% 저급메탄올로 추출하는 제1 단계와, Cordyceps militaris grown in the germinated soybean) extracting with 80% lower methanol,

상기 저급알콜 추출액을 에틸아세테이트로 진탕추출하여 에틸아세테이트 가용부를 회수하는 제2 단계와, A second step of recovering the ethyl acetate soluble portion by shaking the lower alcohol extract with ethyl acetate;

상기 에틸아세테이트 가용부를 젤여과크로마토그래피하여 활성분획을 얻는 제3 단계와, A third step of obtaining an active fraction by gel filtration chromatography of the ethyl acetate soluble part;

상기 활성분획을 감압 농축하는 제4 단계, 및A fourth step of concentrating the active fraction under reduced pressure, and

상기 제4 단계에서 감압 농축된 분말을 고성능 액체 크로마토그래피(High Perfomance Liquid Chromatography)를 이용하여 단일 순수 화합물로 얻는 제5 단계로 이루어진다.The fifth step is to obtain the powder concentrated under reduced pressure in the fourth step as a single pure compound by using high performance liquid chromatography (High Perfomance Liquid Chromatography).

다음에, 발아 대두 동충하초(Cordyceps militaris grown in the germinated soybean)부터 발아 대두 동충하초 추출물 또는 활성물질의 분리과정을 그 단계별로 상세히 설명하면, 먼저, 발아 대두에 동충하초 종균을 접종 배양하여 생산된 발아대두 동충하초를 회수하여 쇄절한다. 그리고, 80% 저급메탄올로 48~72시간 환류추출하고 감압 여과한 후, 그 여액을 20~50℃의 온도에서 감압 농축한다. 그런 다음, 농축된 80% 메탄올 추출액을 과량의 물에 현탁하여 분액여두에 넣은 후 과량의 에틸아세테이트를 넣고 진탕 추출한다. 상등액을 회수하여 40~60℃의 온도에서 감압농축하여 에틸아세테이트 가용부를 얻는다.Next, germinated soybean cordyceps ( Coldyceps militaris grown in the germinated soybean) from the germinated soybean Cordyceps Sinensis extract or the separation process of the active substance in detail step by step, first, seeded soybean Cordyceps inoculated and cultured germinated soybean Cordyceps soybean germinated soybeans. Then, the mixture was refluxed for 48 to 72 hours with 80% lower methanol and filtered under reduced pressure, and the filtrate was concentrated under reduced pressure at a temperature of 20 to 50 ° C. Then, the concentrated 80% methanol extract was suspended in excess water, put into an aliquot, and the excess ethyl acetate was added to shake extraction. The supernatant is recovered and concentrated under reduced pressure at a temperature of 40-60 ° C. to obtain an ethyl acetate soluble part.

농축된 에틸아세테이트 가용부를 소량의 실리카(silica)에 코팅한 후 후 젤여과크로마토그래피하여 활성 분액을 모은다. 이 때, 크로마토그래피로는 실리카 젤 칼럼 크로마토그래피(silica gel column chromatography)를 클로로포름과 메탄올을 이용하여 메탄올의 함유량을 늘려가면서 활성분액을 모은다. 이렇게 얻어진 활성분획들을 액체크로마토그래피 질량 분석 방법(LC/MS)을 이용하여 신규 화합물이 포함된 활성분획을 얻어낸다.The concentrated ethyl acetate soluble part is coated on a small amount of silica (silica), followed by gel filtration chromatography to collect the active aliquots. At this time, the active liquid is collected by increasing the content of methanol using chloroform and methanol in silica gel column chromatography. The active fractions thus obtained are subjected to liquid chromatography mass spectrometry (LC / MS) to obtain active fractions containing new compounds.

다음으로는, 얻어진 활성 분획을 세파덱스 LH-20 젤 칼럼 크로마토그래 피(sephadex LH-20 gel column chromatography)를 수행하여 세분화된 활성 분획을 모은다.Next, the obtained active fractions are subjected to Sephadex LH-20 gel column chromatography to collect the granular active fractions.

그리고, 모아진 활성분액은 40~60℃의 온도에서 감압 농축하여 분말로 얻은 후 소량의 고급 메탄올에 용해한 후 고성능 액체 크로마토그래피(High Perfomance Liquid Chromatography)를 이용하여 단일 순수 화합물로 얻어 낸다. The collected active fractions are concentrated under reduced pressure at a temperature of 40-60 ° C. to obtain a powder, dissolved in a small amount of higher methanol, and then obtained as a single pure compound using high performance liquid chromatography (High Perfomance Liquid Chromatography).

이상의 추출 분리공정에 의해 최종적으로 분리된 활성화합물은 현재까지 보고 되지 않은 신규 이소 플라본계열 화합물인바, 따라서 본 발명은 발아 대두 동충하초의 추출물 또는 상기 화학식 1, 2, 3, 4로 표시되는 신규 이소 플라본 계열 화합물이 및 이의 약학적으로 허용 가능한 염을 포함한다.The active compound finally separated by the above extraction separation process is a novel isoflavone-based compound which has not been reported to date. Thus, the present invention provides an extract of germinated soybean Cordyceps sinensis or a novel isoflavone represented by Chemical Formulas 1, 2, 3, and 4. Family compounds and their pharmaceutically acceptable salts.

상기 화학식 1, 2, 3, 4로 표시되는 화합물은 약학적으로 허용 가능한 염의 형태로 사용할 수 있으며, 염으로는 약학적으로 허용 가능한 유리산(free acid)에 의해 형성된 산 부가염이 유용하다. The compounds represented by the formulas (1), (2), (3) and (4) may be used in the form of a pharmaceutically acceptable salt, and as the salt, an acid addition salt formed by a pharmaceutically acceptable free acid is useful.

상기 화학식 1, 2, 3, 4로 표시되는 화합물은 당해 기술 분야에서 통상적인 방법에 따라 약학적으로 형용되는 산 부가염을 형성할 수 있다. Compounds represented by the formula (1), (2), (3), (4) may form an acid addition salt which is pharmaceutically adhering according to a conventional method in the art.

유리산으로는 유리산과 무기산을 사용할 수 있으며, 무기산으로는 염산, 브롬산, 황산, 인산 등을 사용할 수 있고 유기산으로는 구연산(citric acid), 초산, 젖산, 주석산(tartaric acid), 말레인산, 푸마르산(fumaric acid), 포름산, 프로피온산(propionic acid), 옥살산, 트리플루오로아세트산, 벤조산, 글루콘산, 메탄술폰산, 글리콜산, 숙신산, 4-톨루엔술폰산, 갈룩투론산, 엠본산, 글루탐산 또는 아스파르트산 등을 사용할 수 있다.Free acid and inorganic acid may be used as the free acid, hydrochloric acid, bromic acid, sulfuric acid, phosphoric acid, etc. may be used as the inorganic acid, and citric acid, acetic acid, lactic acid, tartaric acid, maleic acid, and fumaric acid may be used as the organic acid. (fumaric acid), formic acid, propionic acid, oxalic acid, trifluoroacetic acid, benzoic acid, gluconic acid, methanesulfonic acid, glycolic acid, succinic acid, 4-toluenesulfonic acid, galluxuronic acid, embonic acid, glutamic acid or aspartic acid Can be used.

본 발명의 신규 화합물을 의약품으로 사용하는 경우, 발아 대두 동충하초의 추출물 또는 상기 화학식 1, 2, 3, 4로 표시되는 화합물 또는 약학적으로 허용 가능한 염을 임상적으로 이용시에는 약학적 분야에서 통상적인 담체와 함께 배합하여 약학적 분야에서 통상적인 제제, 예를 들면 정제, 캅셀제, 트로키제, 액제, 현탁제 등의 경구투여용 제제와, 주사용 용액 또는 현탁액, 또는 주사시에 주사용 증류수로 제조하여 사용할 수 있는 즉시 사용형 주사용 건조분말 등의 형태인 주사용 제제와, 연고제 등의 다양한 제제로 제형화할 수 있다. In the case of using the novel compound of the present invention as a medicine, the extract of germinated soybean Cordyceps sinensis or the compound represented by the above formulas (1), (2), (3) and (4), or a pharmaceutically acceptable salt thereof is conventionally used in the pharmaceutical field. Formulated with a carrier to prepare conventional oral preparations in the pharmaceutical field, such as tablets, capsules, troches, solutions, suspensions, and the like, and solutions or suspensions for injection, or distilled water for injection at the time of injection. It may be formulated into a variety of preparations, such as injectable preparations in the form of dry powders for injection, ready-to-use injections, and ointments.

통상적인 담체를 상용하여 제조된 약학적 제제는 경구적으로 투여하거나, 비경구적으로 예를 들면 정맥 내, 피하, 복강 내 또는 국소 적용할 수 있다.Pharmaceutical formulations prepared using conventional carriers can be administered orally or parenterally, for example, intravenously, subcutaneously, intraperitoneally or topically.

본 발명의 발아 대두 동충하초 추출물 또는 상기 화학식 1, 2, 3, 4로 표시되는 화합물의 투여량은 환자의 나이, 상태 등에 따라 차이가 있으나, 일반적으로 성인에게 1일에 10~500㎎, 바람직하게는 50~300㎎의 양이 투여되도록 하며, 의사 또는 약사의 판단에 따라 일정시간 간격으로 1일 수회, 바람직하기로는 1회 내지는 6회 분할 투여할 수 있다.The dosage of the germinated soybean Cordyceps Sinensis extract of the present invention or the compound represented by Formulas 1, 2, 3, and 4 may vary depending on the age, condition, etc. of the patient, and generally 10 to 500 mg per day, preferably to adults. The amount of 50 to 300mg is to be administered, and may be divided into several times a day, preferably once to six times at regular intervals according to the judgment of the doctor or pharmacist.

이와 같은 본 발명을 실시예에 의거하여 상세히 설명하면 다음과 같은 바, 본 발명이 하기의 실시예에 한정되는 것은 아니다.When the present invention will be described in detail with reference to Examples, the present invention is not limited to the following Examples.

실시예 1 : 발아 대두 동충하초 추출물의 제조Example 1 Preparation of Germinated Soybean Cordyceps Sinensis Extract

발아대두에 동충하초 종균을 접종 배양하여 생산된 발아대두 동충하초를 쇄 절하고 80% 메탄올로 48~72 시간 동안 환류추출하여 감압여과한 후 그 여액을 40℃의 수조에서 감압 농축하여 농축된 메탄올 농축액을 1L의 증류수에 현탁하였다. 증류수에 현탁시킨 메탄올 추출물은 분액여두에서 2L의 에틸아세테이트로서 진탕추출하여 에틸아세테이트 가용부를 추출하여 얻은 다음 다시 추출액을 50℃의 수조에서 감압 농축하였다. 농축 후 얻어진 엑기스는 엑기스 총량의 10배의 증류수로 3회 공비 농축하고 동량의 증류수를 가하여 균질하게 현탁시킨 뒤, 동결 건조시켜 분말 상태의 발아대두 동충하초 추출물을 얻었다. Inoculate germinated soybean seedlings with germinated soybean seed inoculated and cultured, germinated soybeans, and reflux-extracted with 80% methanol for 48 ~ 72 hours, filter under reduced pressure, and concentrate the filtrate under reduced pressure in a 40 ℃ water bath. It was suspended in 1 L of distilled water. The methanol extract suspended in distilled water was extracted with 2 L of ethyl acetate in a separatory filter, extracted with an ethyl acetate soluble part, and the extract was concentrated under reduced pressure in a 50 ° C. water bath. The extract obtained after concentration was azeotropically concentrated three times with distilled water of 10 times the total amount of the extract, and the same amount of distilled water was added to suspend homogeneously.

실시예 2 : 발아대두 동충하초 추출물로부터 활성화합물의 단리Example 2 Isolation of Active Compound from Germinated Soybean Cordyceps Sinensis Extract

상기 실시예 1에서 얻은 참싸리 추출물 20g을 적당량의 실리카에 코팅시킨 후 실리카 젤 칼럼 크로마토그래피를 클로로포름과 메탄올을 이용하여 메탄올의 함량을 변화시켜 수행하여 활성분획을 모았다. 상기 활성분획을 85% 메탄올을 용출용매로 이용하는 세파덱스 LH-20 젤 크로마토그래피를 수행하여 활성분획을 분리하고 감압건조기로 용매를 제거한 후 얻은 잔사(residue)를 고급 메탄올에 용해하여 고성능 액체 크로마토그래피(High Perfomance Liquid Chromatography)를 수행해 다음과 같은 활성물질(화학식 1, 2, 3, 4)을 얻었다.After coating 20g of the Champsacaceae extract obtained in Example 1 on an appropriate amount of silica, silica gel column chromatography was performed by changing the content of methanol using chloroform and methanol to collect the active fraction. Separation of the active fraction by Sepadex LH-20 gel chromatography using 85% methanol as the elution solvent, and removal of the solvent using a reduced pressure dryer, the residue obtained by dissolving in high-performance methanol (High Perfomance Liquid Chromatography) was performed to obtain the following active substances (Formula 1, 2, 3, 4).

활성물질 각각에 대해서는 LC-ESI-MS(Liquid chromatography electron spray ionization mass spectrometer), 핵자기 공명 스펙트럼 등의 방법을 이용하여 이화학적 특성을 분석하였고, 그 결과 다음과 같은 이화학적 특성을 갖는 것으로 확인되었다.For each active material, physicochemical properties were analyzed using LC-ESI-MS (Liquid Chromatography Electron Spray Ionization Mass Spectrometer) and nuclear magnetic resonance spectra. .

(화학식 1)(Formula 1)

Figure 112008072659540-pat00009
Figure 112008072659540-pat00009

① 물질 성상 : 분말① Material Property: Powder

② 분자량 : 430.3② Molecular Weight: 430.3

③ 분자식 : C22H22O9 ③ Molecular Formula: C 22 H 22 O 9

④ 질량분석치[M-H]- : 429(m/z)④ Mass Spec. [MH] - : 429 ( m / z )

또한, 듀트로 메탄올을 용매로 이용하여 측정한 수소 핵자기공명 스펙트럼 및 탄소 핵자기공명 스펙트럼 분석결과, 상기 화학식 1로 표시되는 화합물로 판명되었다(도 1a 및 도 1b 참조).In addition, hydrogen nuclear magnetic resonance spectra and carbon nuclear magnetic resonance spectra measured using methanol as a solvent were found to be compounds represented by Chemical Formula 1 (see FIGS. 1A and 1B).

(화학식 2)(Formula 2)

Figure 112008072659540-pat00010
Figure 112008072659540-pat00010

① 물질 성상 : 분말① Material Property: Powder

② 분자량 : 460.14② Molecular Weight: 460.14

③ 분자식 : C23H24O10 ③ Molecular Formula: C 23 H 24 O 10

④ 질량분석치[M-H]- : 459(m/z)④ Mass Spec. [MH] - : 459 ( m / z )

또한, 듀트로 메탄올을 용매로 이용하여 측정한 수소 핵자기공명 스펙트럼 및 탄소 핵자기공명 스펙트럼 분석결과, 상기 화학식 2로 표시되는 화합물로 판명되었다(도 2a, 도 2b 참조).In addition, hydrogen nuclear magnetic resonance spectra and carbon nuclear magnetic resonance spectra measured using methanol as a solvent, were found to be compounds represented by Chemical Formula 2 (see FIGS. 2A and 2B).

(화학식 3)(Formula 3)

Figure 112008072659540-pat00011
Figure 112008072659540-pat00011

① 물질 성상 : 분말① Material Property: Powder

② 분자량 : 446.12② Molecular Weight: 446.12

③ 분자식 : C22H22O10 ③ Molecular Formula: C 22 H 22 O 10

④ 질량분석치[M-H]- : 445(m/z)④ Mass Spec. [MH] - : 445 ( m / z )

또한, 듀트로 메탄올을 용매로 이용하여 측정한 수소 핵자기공명 스펙트럼 및 탄소 핵자기공명 스펙트럼 분석결과, 상기 화학식 3으로 표시되는 화합물로 판명되었다(도 3a, 도 3b 참조).In addition, hydrogen nuclear magnetic resonance spectra and carbon nuclear magnetic resonance spectra were measured using methanol as a solvent. As a result, it was found to be a compound represented by Chemical Formula 3 (see FIGS. 3A and 3B).

(화학식 4)(Formula 4)

Figure 112008072659540-pat00012
Figure 112008072659540-pat00012

① 물질 성상 : 분말① Material Property: Powder

② 분자량 : 446.12② Molecular Weight: 446.12

③ 분자식 : C22H22O10 ③ Molecular Formula: C 22 H 22 O 10

④ 질량분석치[M-H]- : 445(m/z)④ Mass Spec. [MH] - : 445 ( m / z )

또한, 듀트로 메탄올을 용매로 이용하여 측정한 수소 핵자기공명 스펙트럼 및 탄소 핵자기공명 스펙트럼 분석결과, 상기 화학식 4로 표시되는 화합물로 판명되었다(도 4a, 도 4b 참조).In addition, hydrogen nuclear magnetic resonance spectra and carbon nuclear magnetic resonance spectra measured using methanol as a solvent, were found to be compounds represented by Chemical Formula 4 (see FIGS. 4A and 4B).

도 1a는 화학식 1로 표시되는 화합물의 수소 핵자기공명(1H-NMR) 스펙트럼(spectrum)을 나타낸 것이고,Figure 1a shows a hydrogen nuclear magnetic resonance ( 1 H-NMR) spectrum of the compound represented by Formula 1,

도 1b는 화학식 1로 표시되는 화합물의 탄소 핵자기공명(13C-NMR) 스펙트럼(spectrum)을 나타낸 것이며,Figure 1b shows the carbon nuclear magnetic resonance ( 13 C-NMR) spectrum of the compound represented by Formula 1,

도 2a는 화학식 2로 표시되는 화합물의 수소 핵자기공명(1H-NMR) 스펙트럼(spectrum)을 나타낸 것이며,Figure 2a shows a hydrogen nuclear magnetic resonance ( 1 H-NMR) spectrum of the compound represented by Formula 2,

도 2b는 화학식 2로 표시되는 화합물의 탄소 핵자기공명(13C-NMR) 스펙트럼(spectrum)을 나타낸 것이며, Figure 2b shows the carbon nuclear magnetic resonance ( 13 C-NMR) spectrum of the compound represented by Formula 2,

도 3a는 화학식 3로 표시되는 화합물의 수소 핵자기공명(1H-NMR) 스펙트럼(spectrum)을 나타낸 것이며,Figure 3a shows a hydrogen nuclear magnetic resonance ( 1 H-NMR) spectrum of the compound represented by Formula 3,

도 3b는 화학식 3로 표시되는 화합물의 탄소 핵자기공명(13C-NMR) 스펙트럼(spectrum)을 나타낸 것이며, Figure 3b shows the carbon nuclear magnetic resonance ( 13 C-NMR) spectrum of the compound represented by Formula 3,

도 4a는 화학식 4로 표시되는 화합물의 수소 핵자기공명(1H-NMR) 스펙트럼(spectrum)을 나타낸 것이며,Figure 4a shows a hydrogen nuclear magnetic resonance ( 1 H-NMR) spectrum of the compound represented by Formula 4,

도 4b는 화학식 4로 표시되는 화합물의 탄소 핵자기공명(13C-NMR) 스펙트럼(spectrum)을 나타낸 것이다.Figure 4b shows the carbon nuclear magnetic resonance ( 13 C-NMR) spectrum of the compound represented by the formula (4).

Claims (3)

하기 화학식 1, 2, 3, 4로 표시되는 이소플라본 계열 화합물인 것을 특징으로 하는 발아 대두 동충하초로부터 분리된 신규 이소플라본 계열 화합물.A novel isoflavone-based compound isolated from germinated soybean cordyceps, characterized in that the isoflavone-based compound represented by the formula (1), (2), (3), (4). (화학식 1)(Formula 1)
Figure 112008072659540-pat00013
Figure 112008072659540-pat00013
(화학식 2)(Formula 2)
Figure 112008072659540-pat00014
Figure 112008072659540-pat00014
(화학식 3)(Formula 3)
Figure 112008072659540-pat00015
Figure 112008072659540-pat00015
(화학식 4)(Formula 4)
Figure 112008072659540-pat00016
Figure 112008072659540-pat00016
삭제delete 삭제delete
KR1020080102519A 2008-10-20 2008-10-20 New isoflavonoids of Cordyceps militaris grown in the germinated soybean KR101086528B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020080102519A KR101086528B1 (en) 2008-10-20 2008-10-20 New isoflavonoids of Cordyceps militaris grown in the germinated soybean

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020080102519A KR101086528B1 (en) 2008-10-20 2008-10-20 New isoflavonoids of Cordyceps militaris grown in the germinated soybean

Publications (2)

Publication Number Publication Date
KR20100043471A KR20100043471A (en) 2010-04-29
KR101086528B1 true KR101086528B1 (en) 2011-11-23

Family

ID=42218440

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020080102519A KR101086528B1 (en) 2008-10-20 2008-10-20 New isoflavonoids of Cordyceps militaris grown in the germinated soybean

Country Status (1)

Country Link
KR (1) KR101086528B1 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100561251B1 (en) * 2003-03-21 2006-03-15 주식회사 에스티씨나라 Composition comprising the extract of Glycine max having monoamine oxidase-inhibiting activity

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100561251B1 (en) * 2003-03-21 2006-03-15 주식회사 에스티씨나라 Composition comprising the extract of Glycine max having monoamine oxidase-inhibiting activity

Also Published As

Publication number Publication date
KR20100043471A (en) 2010-04-29

Similar Documents

Publication Publication Date Title
EP1942093B1 (en) Novel cyclohexenone compounds from antrodia camphorata and application thereof
CN109705188B (en) Triterpenoid compound in exocarpium Juglandis Immaturum, and preparation method and application thereof
CN113105388B (en) Euphorbia lathyris diterpene alkyl compound and extraction method and application thereof
EP1559703B1 (en) A natural compound useful for treating diabetes, its preparation and use
CN113004297B (en) Diterpene alkaloid compound and extraction method and application thereof
CN107837301B (en) Piper laetispicum extract and preparation method and application thereof
KR101086528B1 (en) New isoflavonoids of Cordyceps militaris grown in the germinated soybean
CN111205347A (en) Oleanane-type triterpenoid saponin compound and extraction method and application thereof
CN101591316B (en) Homoisoflavone, dihydrohomoisoflavone and homoisoflavane derivatives and application thereof
KR101135177B1 (en) Tyrosinase inhibiting compound isolated from Lespedeza cyrtobotrya MIQ, pharmaceutical compositions the same and use thereof
CN114835668A (en) Preparation method and application of cyclic ether type diaryl heptane in exocarpium Juglandis Immaturum
CN114605422A (en) A pair of enantiomer alkaloid dimer compounds, and preparation method and application thereof
CN110204589B (en) Effective component of feather cockscomb seed, extraction method and application thereof in preparing neuroprotective medicament
US6489514B1 (en) (-)-Secoisolariciresinol as an antioxidant obtained from a new natural source namely stereospermum personatum
KR101999273B1 (en) Preparation methods of high quality Cordycepin, Cordyceps militaris containing high quantity of Cordycepin and high quality Cordycepin obtained by the same
CN107686501B (en) Extraction method of cucurbitane type triterpenoid and anti-aging medical application thereof
CN111217886B (en) Ursolic triterpenoid saponin compound and preparation method and application thereof
CN113024551B (en) Compound extracted and separated from brucea javanica, and preparation method and application thereof
CN114031624B (en) Spirocyclic flavanol alkaloid and preparation method and application thereof
CN115073432B (en) Methylated flavanol alkaloid and extraction, synthesis, detection and application thereof
CN115710172B (en) Diterpenoid compound in euphorbia pekinensis, and extraction method and application thereof
KR101259565B1 (en) Tyrosinase inhibiting compound isolated from Lespedeza cyrtobotrya MIQ, pharmaceutical compositions the same and use thereof
CN114605247B (en) Diterpenoid derivative, preparation method thereof, analgesic, and ethyl acetate extract of fermentation product of Pleurotus cornucopiae
KR101413374B1 (en) The Novel α-cubebenoate compound isolated from Schisandra chinensis
KR101342095B1 (en) Methoxy flavonoid compounds and Isolation Method Thereof

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee